Engineering the Iron Center: Hemin Nanozymes for Programmable Cancer Catalysis
(opens in new window)
Author(s):
Amir M. Alsharabasy, Godspower T. Isaac, Abhay Pandit
Published in:
Nano Letters, 2026, ISSN 1530-6984
Publisher:
American Chemical Society (ACS)
DOI:
10.1021/ACS.NANOLETT.6C00429
VA1213, a selective COX-2 inhibitor, exhibits antitumor activity by suppressing EGFR, AKT, and ERK1/2 phosphorylation
(opens in new window)
Author(s):
Valerio Ciccone, Claudia Cecchin, Maria Frosini, Mario Saletti, Samuele Maramai, Germano Giuliani, Marco Paolino, Andrea Cappelli, Maurizio Anzini, Sandra Donnini, Lucia Morbidelli
Published in:
European Journal of Pharmaceutical Sciences, Issue 219, 2026, ISSN 0928-0987
Publisher:
Elsevier BV
DOI:
10.1016/J.EJPS.2025.107422
Crosstalk between S-nitrosylation and glycation defines a metabolic vulnerability in liver and renal cancers
(opens in new window)
Author(s):
Chiara Pecorari, Mojca Bratina, Evelyn Gonzalez, Salvatore Rizza, Letizia Incampo, Lina Vardouli, Paola Giglio, Elena Maresca, Zsófia Márta Sztupinszki, Marcus Montanares Kildegaard Nielsen, Perrine Verdys, Mario Presti, Maria Pires Pacheco, Yuya Qiu, Samuel D. Mador, Trine Skov Petersen, Julie Lund Petersen, Yonglun Luo, Emmanuelle Bignon, Zoltan Szallasi, Marco Donia, Jonathan S. Stamler, Simone Cardaci, Thomas Sauter, Giuseppe Filomeni
Published in:
Nature Communications, Issue 17, 2026, ISSN 2041-1723
Publisher:
Springer Science and Business Media LLC
DOI:
10.1038/S41467-026-76938-X